STXBP2
protein-codingsyntaxin binding protein 2
Gene summary
This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013135
Submitter: ClinGen
*STXBP2* was first reported in relation to autosomal recessive familial hemophagocytic lymphohistiocytosis 5 (FHL5) in 2009 (zur Stadt U, et al., 2009, PMID: 19804848). FHL is a hyperinflammatory syndrome caused by an uncontrolled and ineffective proliferation and activation of T lymphocytes, natural killer (NK) cells, and macrophages that infiltrate multiple organs, including liver, spleen, lymph nodes, and central nervous system (CNS), and produce massive amounts of cytokines. This overwhelming hyperimmune status results in a clinical picture characterized by persistent fever, hepatosplenomegaly, pancytopenia, hemophagocytosis in various tissues, coagulation abnormalities, and inflammatory CNS disease. Patients with FHL5 have several unique features, including sensorineural hearing deficit, abnormal bleeding, and severe diarrhea. *STXBP2* is involved in intracellular vesicle trafficking and vesicle fusion with membranes, it contributes to the granule exocytosis machinery through interaction with soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins that regulate membrane fusion. The role of *STXBP2* in the cytotoxic granule pathway, and how variation in the gene results in FHL5 is currently not understood in detail but the mechanism of disease appears to be loss of function. This curation includes eleven variants (including in-frame deletions, missense, splicing, and frameshift) found in ten probands from two publications (PMIDs: 19804848, 22451424). Additional cases are available in the literature however the maximum score for genetic evidence has been reached. A role in disease is supported by increased expression of *STXBP2* in NK cells, T cells, monocytes, and other hematopoietic cells (PMID: 19804848), which is altered in patients (PMID: 19884660), resulting in altered cytotoxicity of patient NK cells and cytotoxic T-lymphocytes (PMID: 19804848). Additionally, degranulation defects were rescued in patient cells with wildtype *STXBP2* (PMID: 19884660). *STXBP2* is also known to interact with *STX11*, which has a well established relationship with FHL (PMID: 19804848). In summary *STXBP2* is definitively associated with autosomal recessive FHL5. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0015541
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013135
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013135
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009635
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013135
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013135
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Gastrointestinal; Neurologic
Intervention: Allergy/Immunology/Infectious; Gastrointestinal
Rationale: Antibiotics or antiviral agents can be beneficial to treat/prevent infections that can trigger an exaggerated inflammatory response; The condition can involve hematologic manifestations as well as enteropathy, and awareness may allow medical (eg, with anti-interferon-gamma antibody and corticosteroids) and nutritional interventions related to the sequelae; Chemo/immunotherapy can achieve clinical stability prior to allogeneic hematopoietic cell transplantation (HCT), the only curative therapy.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to STXBP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006949.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 288 | 1 | 298 | ||
| missense | 3 | 15 | 357 | 25 | 400 | |
| nonsense | 17 | 8 | 3 | 28 | ||
| start loss | 0 | |||||
| frameshift | 22 | 14 | 1 | 37 | ||
| splice donor/acceptor (+/-2bp) | 2 | 29 | 4 | 35 | ||
| Total | 44 | 66 | 374 | 313 | 1 | 798 |
Highest pathogenic variant AF is 0.00033532793
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008880.2 | 19 | MANE Select | |
| Ensembl | ENSP00000221283.4 | 19 | MANE Select | |
| RefSeq | NP_001120868.1 | 19 | Standard | |
| RefSeq | NP_001258963.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Splicing factor NOVA regulated synaptic proteins
- Insulin Signaling
- Other interleukin signaling
- Signaling by Interleukins
- Cytokine Signaling in Immune system
Biological Process
- leukocyte mediated cytotoxicity
- platelet degranulation
- vesicle docking involved in exocytosis
- protein transport
- regulation of mast cell degranulation
Molecular Function
- protein binding
- syntaxin-1 binding
- syntaxin-3 binding
Cellular Component
- extracellular region
- cytosol
- plasma membrane
- apical plasma membrane
- specific granule
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000221283
- Coding exons
- 19
- Length
- 10993
- Individuals with no LoFs
- 125716
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 125748
- p
- 0.000127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.481 | 344 | 370 | 0.930 | 0.0000256 | 3831 |
| Missense (PolyPhen) | 120 | 134.26 | 0.89378 | 1559 | ||
| Synonymous | -1.15 | 180 | 161 | 1.11 | 0.0000122 | 1178 |
| Loss of Function | 2.24 | 17 | 30.3 | 0.561 | 0.00000132 | 385 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in intracellular vesicle trafficking and vesicle fusion with membranes. Contributes to the granule exocytosis machinery through interaction with soluble N- ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins that regulate membrane fusion. Regulates cytotoxic granule exocytosis in natural killer (NK) cells. {ECO:0000269|PubMed:19804848, ECO:0000269|PubMed:19884660}.;
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- LoFtool
- 0.607
- RVIS EVS
- 0.43
- RVIS percentile EVS
- 77.29
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.781
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |